Incannex Healthcare (IXHL) Net Cash Flow (2023 - 2026)
Incannex Healthcare (IXHL) posted Net Cash Flow of $2.3 million for Q1 2026, up 161.22% sequentially from -$3.7 million in Q4 2025, and down 51.2% YoY from $4.6 million in Q1 2025.
Incannex Healthcare (IXHL) Net Cash Flow (2023 - 2026) Analysis & Trends
Incannex Healthcare has reported Net Cash Flow for 4 years, with the latest figure at $2.3 million in Q1 2026.
- Quarterly Net Cash Flow fell 51.2% year-over-year to $2.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $64.6 million (up 2342.51% YoY) and the FY2025 annual result came in at $8.9 million, up 155.05% from the prior year.
- Net Cash Flow grew to $2.3 million in Q1 2026 per IXHL's latest filing, from -$3.7 million in the prior quarter.
- Over five years, Net Cash Flow peaked at $57.9 million in Q3 2025 and troughed at -$6.0 million in Q3 2023.
- A 4-year average of $3.4 million and a median of -$2.3 million in 2024 frame the typical range for Net Cash Flow.
- The widest YoY moves for Net Cash Flow: up 2622.2% in 2025, down 136.77% in 2025.
- Over 4 years, Net Cash Flow stood at -$2.2 million in 2023, then gained by 28.17% to -$1.6 million in 2024, then slumped by 136.77% to -$3.7 million in 2025, then soared by 161.22% to $2.3 million in 2026.
- According to Business Quant data, Net Cash Flow over the past three periods registered $2.3 million, -$3.7 million, and $57.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | -81.00 Mn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | -458.00 Mn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | -881.03 Mn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | 523.50 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | -912.40 Mn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | 64.40 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | 93.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Incannex Healthcare | 44.39 Mn | 44.39 Mn | - | 2.25 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.25 Mn |
| Mar 31, 2026 | 2.25 Mn |
| Dec 31, 2025 | -3.68 Mn |
| Dec 31, 2025 | -3.68 Mn |
| Sep 30, 2025 | 57.94 Mn |
| Sep 30, 2025 | 57.94 Mn |
| Jun 30, 2025 | 8.12 Mn |
| Jun 30, 2025 | 8.12 Mn |
| Mar 31, 2025 | 4.61 Mn |
| Mar 31, 2025 | 4.61 Mn |
| Dec 31, 2024 | -1.55 Mn |
| Dec 31, 2024 | -1.55 Mn |
| Sep 30, 2024 | -2.30 Mn |
| Sep 30, 2024 | -2.30 Mn |
| Jun 30, 2024 | -3.65 Mn |
| Jun 30, 2024 | -3.65 Mn |
| Mar 31, 2024 | -4.35 Mn |
| Mar 31, 2024 | -4.35 Mn |
| Dec 31, 2023 | -2.16 Mn |
| Dec 31, 2023 | -2.16 Mn |